Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation.

Abstract

Vascular access complications (VACs) remain one of the biggest challenges when performing transcatheter aortic valve implantation (TAVI). This study aimed to investigate the short- and medium-term safety and efficacy of the Viabahn endoprosthesis (Gore, Flagstaff, AZ) when used to treat TAVI-induced vascular injury. Over a 40-month period, 354 patients… (More)
DOI: 10.1016/j.amjcard.2015.01.547

Topics

Cite this paper

@article{Backer2015SafetyAE, title={Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation.}, author={Ole de Backer and Samer Arnous and Benjamin Vikj{\ae}r Sandholt and Matthew Brooks and Luigi Biasco and O. Franzen and Lars L{\"o}nn and Bo Bech and Lars S\ondergaard}, journal={The American journal of cardiology}, year={2015}, volume={115 8}, pages={1123-9} }